Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes

Journal of Immunology

Volumn 189, Issue 12, 2012, Pages 5877-5885

  Xu, Mei Hui ^a   Hadinoto, Vey ^a   Appanna, Ramapraba ^a   Joensson, Klas ^a   Toh, Ying Xiu ^a   Balakrishnan, Thavamalar ^a   Ong, Swee Hoe ^b   Warter, Lucile ^a   Leo, Yee Sin ^c   Wang, Cheng I ^a   Fink, Katja ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; RECOMBINANT ANTIBODY; VIRUS GLYCOPROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CASE REPORT; CELL SELECTION; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 2; DENGUE VIRUS 3; HUMAN; HUMAN CELL; MEMORY CELL; MOUSE; NONHUMAN; PLASMA CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECURRENT INFECTION; SECONDARY INFECTION; SEQUENCE ANALYSIS; SEROTYPE; VIRUS NEUTRALIZATION;

ADULT; ANIMALS; BINDING SITES, ANTIBODY; CAPSID PROTEINS; CELL DIFFERENTIATION; DENGUE; DENGUE VIRUS; EPITOPES, B-LYMPHOCYTE; HUMANS; IMMUNOLOGIC MEMORY; MICE; PLASMA CELLS; PROTEIN BINDING; RECURRENCE; SEROTYPING; VIRAL ENVELOPE PROTEINS; VIRION; YOUNG ADULT;

EID: 84871134354     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201688     Document Type: Article

References (45)

1. Dung, N. T., H. T. Duyen, N. T. Thuy, T. V. Ngoc, N. V. Chau, T. T. Hien, S. L. Rowland-Jones, T. Dong, J. Farrar, B. Wills, and C. P. Simmons. 2010. Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J. Immunol. 184: 7281-7287.
2. Duyen, H. T., T. V. Ngoc, D. T. Ha, V. T. Hang, N. T. Kieu, P. R. Young, J. J. Farrar, C. P. Simmons, M. Wolbers, and B. A. Wills. 2011. Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status. J. Infect. Dis. 203: 1292-1300.
3. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, and A. Nisalak. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181: 2-9. (Pubitemid 30049026)
4. Bozza, F. A., O. G. Cruz, S. M. Zagne, E. L. Azeredo, R. M. Nogueira, E. F. Assis, P. T. Bozza, and C. F. Kubelka. 2008. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect. Dis. 8: 86.
5. Simmons, C. P., S. Popper, C. Dolocek, T. N. Chau, M. Griffiths, N. T. Dung, T. H. Long, D. M. Hoang, N. V. Chau, T. T. Thao, et al. 2007. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J. Infect. Dis. 195: 1097-1107. (Pubitemid 46543440)
6. Balakrishnan, T., D. B. Bela-Ong, Y. X. Toh, M. Flamand, S. Devi, M. B. Koh, M. L. Hibberd, E. E. Ooi, J. G. Low, Y. S. Leo, et al. 2011. Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. PLoS ONE 6: e29430.
7. Chau, T. N., N. T. Quyen, T. T. Thuy, N. M. Tuan, D. M. Hoang, N. T. Dung, B. Lien, N. T. Quy, N. T. Hieu, L. T. Hieu, et al. 2008. Dengue in Vietnamese infants - results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J. Infect. Dis. 198: 516-524.
8. Mongkolsapaya, J., W. Dejnirattisai, X. N. Xu, S. Vasanawathana, N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9: 921-927. (Pubitemid 36889936)
9. Flamand, M., F. Megret, M. Mathieu, J. Lepault, F. A. Rey, and V. Deubel. 1999. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73: 6104-6110. (Pubitemid 29274901)
10. Yoksan, S., K. Tubthong, W. Kanitwithayanun, and N. Jirakanjanakit. 2009. Laboratory assays and field dengue vaccine evaluation at Ratchaburi province, Thailand: a preliminary result. J. Clin. Virol. 46(Suppl. 2): S13-S15.
11. Tricou, V., N. N. Minh, J. Farrar, H. T. Tran, and C. P. Simmons. 2011. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl. Trop. Dis. 5: e1309.
12. Sabin, A. B. 1952. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1: 30-50.
13. Beltramello, M., K. L. Williams, C. P. Simmons, A. Macagno, L. Simonelli, N. T. Quyen, S. Sukupolvi-Petty, E. Navarro-Sanchez, P. R. Young, A. M. de Silva, et al. 2010. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8: 271-283.
14. de Alwis, R., M. Beltramello, W. B. Messer, S. Sukupolvi-Petty, W. M. Wahala, A. Kraus, N. P. Olivarez, Q. Pham, J. D. Brien, W. Y. Tsai, et al. 2011. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl. Trop. Dis. 5: e1188.
15. Dejnirattisai, W., A. Jumnainsong, N. Onsirisakul, P. Fitton, S. Vasanawathana, W. Limpitikul, C. Puttikhunt, C. Edwards, T. Duangchinda, S. Supasa, et al. 2010. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328: 745-748.
16. Schieffelin, J. S., J. M. Costin, C. O. Nicholson, N. M. Orgeron, K. A. Fontaine, S. Isern, S. F. Michael, and J. E. Robinson. 2010. Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol. J. 7: 28.
17. Wrammert, J., N. Onlamoon, R. S. Akondy, G. C. Perng, K. Polsrila, A. Chandele, M. Kwissa, B. Pulendran, P. C. Wilson, O. Wittawatmongkol, et al. 2012. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J. Virol. 86: 2911-2918.
18. Halstead, S. B., S. Rojanasuphot, and N. Sangkawibha. 1983. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg. 32: 154-156. (Pubitemid 13186851)
19. Midgley, C. M., M. Bajwa-Joseph, S. Vasanawathana, W. Limpitikul, B. Wills, A. Flanagan, E. Waiyaiya, H. B. Tran, A. E. Cowper, P. Chotiyarnwong, et al. 2011. An in-depth analysis of original antigenic sin in dengue virus infection. J. Virol. 85: 410-421.
20. Low, J. G., E. E. Ooi, T. Tolfvenstam, Y. S. Leo, M. L. Hibberd, L. C. Ng, Y. L. Lai, G. S. Yap, C. S. Li, S. G. Vasudevan, and A. Ong. 2006. Early Dengue infection and outcome study (EDEN) - study design and preliminary findings. Ann. Acad. Med. Singapore 35: 783-789. (Pubitemid 46045347)
21. Schreiber, M. J., E. C. Holmes, S. H. Ong, H. S. Soh, W. Liu, L. Tanner, P. P. Aw, H. C. Tan, L. C. Ng, Y. S. Leo, et al. 2009. Genomic epidemiology of a dengue virus epidemic in urban Singapore. J. Virol. 83: 4163-4173.
22. McBride, W., and S. Vasudevan. 1995. Relationship of a dengue 2 isolate from Townsville, 1993, to international isolates. Commun. Dis. Intell. 19: 522-523.
23. Smith, K., L. Garman, J. Wrammert, N. Y. Zheng, J. D. Capra, R. Ahmed, and P. C. Wilson. 2009. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4: 372-384.
24. Souto-Carneiro, M. M., N. S. Longo, D. E. Russ, H. W. Sun, and P. E. Lipsky. 2004. Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J. Immunol. 172: 6790-6802. (Pubitemid 38669117)
25. Giudicelli, V., P. Duroux, C. Ginestoux, G. Folch, J. Jabado-Michaloud, D. Chaume, and M. P. Lefranc. 2006. IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res. 34(Database issue): D781-D784.
26. Durocher, Y., S. Perret, and A. Kamen. 2002. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30: E9.
27. Warter, L., C. Y. Lee, R. Thiagarajan, M. Grandadam, S. Lebecque, R. T. Lin, S. Bertin-Maghit, L. F. Ng, J. P. Abastado, P. Desprès, et al. 2011. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. J. Immunol. 186: 3258-3264.
28. Umashankar, M., C. Sánchez-San Martín, M. Liao, B. Reilly, A. Guo, G. Taylor, and M. Kielian. 2008. Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J. Virol. 82: 9245-9253.
29. Kraus, A. A., W. Messer, L. B. Haymore, and A. M. de Silva. 2007. Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 45: 3777-3780. (Pubitemid 350156883)
30. Wrammert, J., K. Smith, J. Miller,W. A. Langley, K. Kokko, C. Larsen, N. Y. Zheng, I. Mays, L. Garman, C. Helms, et al. 2008. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453: 667-671. (Pubitemid 351769295)
31. Dowd, K. A., C. A. Jost, A. P. Durbin, S. S. Whitehead, and T. C. Pierson. 2011. A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. PLoS Pathog. 7: e1002111.
32. Schul, W., W. Liu, H. Y. Xu, M. Flamand, and S. G. Vasudevan. 2007. A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J. Infect. Dis. 195: 665-674.
33. Zhang,W., P. R. Chipman, J. Corver, P. R. Johnson, Y. Zhang, S. Mukhopadhyay, T. S. Baker, J. H. Strauss, M. G. Rossmann, and R. J. Kuhn. 2003. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat. Struct. Biol. 10: 907-912. (Pubitemid 37386099)
34. Oliphant, T., G. E. Nybakken, M. Engle, Q. Xu, C. A. Nelson, S. Sukupolvi- Petty, A. Marri, B. E. Lachmi, U. Olshevsky, D. H. Fremont, et al. 2006. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J. Virol. 80: 12149-12159. (Pubitemid 44904366)
35. Sukupolvi-Petty, S., S. K. Austin, W. E. Purtha, T. Oliphant, G. E. Nybakken, J. J. Schlesinger, J. T. Roehrig, G. D. Gromowski, A. D. Barrett, D. H. Fremont, and M. S. Diamond. 2007. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J. Virol. 81: 12816-12826. (Pubitemid 350156919)
36. Brezinschek, H. P., R. I. Brezinschek, and P. E. Lipsky. 1995. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J. Immunol. 155: 190-202.
37. Liao, H. X., X. Chen, S. Munshaw, R. Zhang, D. J. Marshall, N. Vandergrift, J. F. Whitesides, X. Lu, J. S. Yu, K. K. Hwang, et al. 2011. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J. Exp. Med. 208: 2237-2249.
38. Lee, F. E., J. L. Halliley, E. E. Walsh, A. P. Moscatiello, B. L. Kmush, A. R. Falsey, T. D. Randall, D. A. Kaminiski, R. K. Miller, and I. Sanz. 2011. Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J. Immunol. 186: 5514-5521.
39. de Alwis, R., S. A. Smith, N. P. Olivarez, W. B. Messer, J. P. Huynh, W. M. Wahala, L. J. White, M. S. Diamond, R. S. Baric, J. E. Crowe, Jr., and A. M. de Silva. 2012. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl. Acad. Sci. USA 109: 7439-7444.
40. Teoh, E. P., P. Kukkaro, E. W. Teo, A. P. Lim, T. T. Tan, A. Yip, W. Schul, M. Aung, V. A. Kostyuchenko, Y. S. Leo, et al. 2012. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci. Transl. Med. 4: 139ra83.
41. O'Connor, B. P., L. A. Vogel, W. Zhang, W. Loo, D. Shnider, E. F. Lind, M. Ratliff, R. J. Noelle, and L. D. Erickson. 2006. Imprinting the fate of antigen-reactive B cells through the affinity of the B cell receptor. J. Immunol. 177: 7723-7732. (Pubitemid 44846288)
42. Phan, T. G., D. Paus, T. D. Chan, M. L. Turner, S. L. Nutt, A. Basten, and R. Brink. 2006. High affinity germinal center B cells are actively selected into the plasma cell compartment. J. Exp. Med. 203: 2419-2424. (Pubitemid 44664611)
43. Scheid, J. F., H. Mouquet, N. Feldhahn, M. S. Seaman, K. Velinzon, J. Pietzsch, R. G. Ott, R. M. Anthony, H. Zebroski, A. Hurley, et al. 2009. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458: 636-640.
44. Wu, X., T. Zhou, J. Zhu, B. Zhang, I. Georgiev, C. Wang, X. Chen, N. S. Longo, M. Louder, K. McKee, et al NISC Comparative Sequencing Program. 2011. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333: 1593-1602.
45. Fink, K., C. Ng, C. Nkenfou, S. G. Vasudevan, N. van Rooijen, and W. Schul. 2009. Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control. Eur. J. Immunol. 39: 2809-2821.